Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The Future of Medical Machine Vision - Possibilities for Diagnostics and More

The Future of Medical Machine Vision - Possibilities for Diagnostics and More

FromThe AI in Business Podcast


The Future of Medical Machine Vision - Possibilities for Diagnostics and More

FromThe AI in Business Podcast

ratings:
Length:
28 minutes
Released:
Jan 7, 2018
Format:
Podcast episode

Description

This week’s episode covers the medical applications of machine vision for the diagnosis and treatment of cancer. Medical science has integrated AI since the late 90s, and it’s been useful in the fight against cancer. This week’s guest is Dr. Alexandre Le Bouthillier, founder of Imagia. Imagia is a medical imaging company which specializes in using AI and machine learning to detect cancer in its early stages so that oncologists can make quicker, more accurate diagnoses for patients. AI is a useful  tool in the detection of breast cancer, colon cancer, and lung cancer. It can even detect genetic mutations, something humans certainly cannot. Learn just how important AI has been over the last two decades in developing the medical infrastructure necessary for patients to have a chance at surviving and even curing their cancer. See the full interview article - with images and audio included - on TechEmergence: TechEmergence.com/the-future-of-medical-machine-vision-possibilities-for-diagnostics-and-more
Released:
Jan 7, 2018
Format:
Podcast episode

Titles in the series (100)

Learn what's possible - and what's working - with artificial intelligence in the enterprise. Each week, Emerj founder Daniel Faggella interviews top AI and machine learning-focused executives and researchers in sectors like Pharma, Banking, Retail, Defense, and more. Discover trends, learn about what's working now, and learn how to adapt and thrive in an era of AI disruption. Be sure to subscribe to "AI in Industry."